Navigation Links
Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community

Faith-based program provides ministry with tools and information to sustain

efforts in hepatitis C education, screening and testing

PHILADELPHIA, Aug. 17 /PRNewswire-USNewswire/ -- Roche representatives will work together with the Enon Tabernacle Baptist Church from Saturday, August 18 - Sunday, August 19 to educate the church community about the hepatitis C virus (HCV), including risk factors, the importance of getting tested and possible treatment options.

Preparations will begin on Friday, August 17 when ministry leaders, church volunteers, and Roche representatives convene to review education and testing logistics regarding HCV.

"African Americans have the highest rate of infection with hepatitis C in the country. We are committed to educate and provide free hepatitis C testing to the members of Enon Tabernacle Baptist Church and other local residents to prevent future infections," said Senior Pastor Rev. Dr. Alyn E. Waller, Enon Tabernacle Baptist Church, Philadelphia, PA.

For the past four years, Roche has worked primarily with African-American community churches nationwide to establish HCV testing programs in congregations across the country. In 2006, screening events took place in 30 communities of faith, and an additional 80 events are scheduled in 2007, with the program also extending to Hispanic and Egyptian churches.

"At Roche, we are dedicated to improving the lives of patients and to the communities where they live and worship," said Frank Griffith, Brand Director, Interferons Marketing, Roche. "By providing this congregation with the tools and information it needs to execute HCV education and screenings, it can successfully sustain this valuable community program in the future."

About HCV

According to the American Liver Foundation, more than four million people in the United States are or have been infected with hepatitis C, and an estimated 70 percent are not aware they have the virus.

Hepatitis C is one of six identified hepatitis viruses that cause the liver to become inflamed, which interferes with its ability to function, and is generally considered to be among the most serious of the six hepatitis viruses.(1) HCV is transmitted primarily through direct exposure to blood through an opening in the skin or mucus membrane. The hepatitis C virus infects the liver, causing inflammation resulting in damage of the liver tissue.(2) Many people with chronic hepatitis C have no symptoms of liver disease, but if symptoms are present they are usually mild; may come and go over time; and be hard to recognize as related to hepatitis C. Symptoms may include fatigue, liver pain, nausea, poor appetite or muscle and joint pains.(3) Contact your physician if you experience any of these symptoms.

Additional information about hepatitis C can be found by calling the American Liver Foundation at toll-free 800-GO-Liver (465-4837) or 888-4HEP-USA (443-7872), by visiting its Web site at or by visiting Roche's site: .

(1) September 14, 2005. Accessed on July

25, 2006.

(2) American Liver Foundation. Copyright 2002-2003. Accessed on July 26,


(3) National Digestive Diseases Information Clearinghouse (NDDIC).

February 2003.

Accessed on July 26, 2006.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years, the Roche Group has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2006, Roche was named one of the Top 20 Employers (Science magazine), ranked the No. 1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: or


Copyright©2007 PR Newswire.

Related biology technology :

1. Advantages of Roche Applied Science amplification products
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
5. Prodesse enters patent agreement with Roche
6. Chemical-petroleum executive joins Virent Energy board
7. Schneider National exec joins TrafficCast board
8. Doyle joins governors in support of stem cell bill
9. Genomics researcher Hood joins NimbleGen board
10. Fergus joins Baird Venture Partners, Caden Bio
11. Meier joins Broadlook Technologies as COO
Post Your Comments:
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... ... ... The Academy of Model Aeronautics (AMA), led by its Executive Council, has officially ... to represent the First–Person View (FPV) racing community. , FPV racing has exploded in ... racing and several new model aviation pilots have joined the community because of their ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):